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Purpose: To assess the performance of deep learning algorithms for different tasks in retinal
fundus images: (1) detection of retinal fundus images versus optical coherence tomography (OCT)
or other images, (2) evaluation of good quality retinal fundus images, (3) distinction between right
eye (OD) and left eye (OS) retinal fundus images,(4) detection of age related macular degeneration
(AMD) and (5) detection of referable glaucomatous optic neuropathy (GON).
Patients and Methods: Five algorithms were designed. Retrospective study from a database
of 306,302 images, Optretina’s tagged dataset. Three different ophthalmologists, all retinal
specialists, classified all images. The dataset was split per patient in a training (80%) and testing
(20%) splits. Three different CNN architectures were employed, two of which were custom
designed to minimize the number of parameters with minimal impact on its accuracy. Main
outcome measure was area under the curve (AUC) with accuracy, sensitivity and specificity.
Results: Determination of retinal fundus image had AUC of 0.979 with an accuracy of 96%
(sensitivity 97.7%, specificity 92.4%). Determination of good quality retinal fundus image
had AUC of 0.947, accuracy 91.8% (sensitivity 96.9%, specificity 81.8%). Algorithm for
OD/OS had AUC 0.989, accuracy 97.4%. AMD had AUC of 0.936, accuracy 86.3%
(sensitivity 90.2% specificity 82.5%), GON had AUC of 0.863, accuracy 80.2% (sensitivity
76.8%, specificity 83.8%).
Conclusion: Deep learning algorithms can differentiate a retinal fundus image from other
images. Algorithms can evaluate the quality of an image, discriminate between right or left
eye and detect the presence of AMD and GON with a high level of accuracy, sensitivity and
specificity.
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Introduction
Retinal diseases are on the rise due to the increase of diabetic population and increased
longevity. A good example of the effect of age on retinal health is age-related macular
degeneration (AMD): in 2020, the number of people with this disease is projected to be
196million and is expected to grow to 288million by 2040.1 Glaucoma is a progressive
optic neuropathy, which is the leading cause of blindness in industrialized countries and
ocular hypertension is the main risk factor for glaucoma.2
General screening for retinal diseases and glaucoma in the population is ideal, as
many pathologies can be detected in the early stages, while other diseases—such as
retinal dystrophies, choroidal nevi or epiretinal membranes (ERMs)—can also be
diagnosed and are better managed with early detection. Screening for diabetic
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retinopathy (DR) and AMD is already cost-effective, but
there are no published studies to support the case for
general screening yet. Retinal fundus images using non-
mydriatic cameras (NMC) are currently considered the
gold standard for screening DR3,4 and are also cost-
effective for AMD.5,6 Similarly, screening for premature
retinopathy is supported by many papers, showing good
efficacy and cost-effectiveness.7 The detection of disease
through retinal fundus images has also been shown to
produce competitive results, particularly for neurological8
or cardiovascular9 diseases. However, general screenings
using retinal fundus images have, to the best of our knowl-
edge, never been implemented—even on particularly sen-
sitive segments of the population, such as those over fifty
years old, an age at which retinal pathologies increase
significantly.
Artificial intelligence (AI) and, more specifically, deep
learning, could be helpful in this area. Deep learning is
a set of machine learning techniques that have recently
undergone a renaissance, achieving breakthrough accuracy
in image recognition tasks in different fields from compu-
ter vision10 to the medical sciences, solving problems such
as: detecting melanoma,11 detecting cancer metastases
from pathology images,12 and diagnosing pneumonia
using x-rays.13 We argue that a computer-aided diagnosis
system (CADx), whether fully automated or used in con-
junction with medical specialists, could substantially
reduce the human and economic costs of image analysis.
Furthermore, in the last few years, NMC have become
significantly cheaper; in the near future, any cell phone
could be used as a retinal camera for early screening.
Deep learning has already had success in ophthalmol-
ogy, demonstrating its ability to detect DR in retinal fun-
dus images.14–17 In fact, previous studies report accuracy
of over 90% with sensitivity and specificity levels over
90% as well, which coincides with roughly the same level
as a human ophthalmology expert. We can find similar
outcomes with the detection of referable AMD.18
However, using such algorithms in real-world situations
remains a challenge, as shown by the decreased accuracy
(around 80%) achieved in prospective studies.19 This
decrease could be due to inconsistent image quality and
other aspects, such as comorbidity. Dataset quality assess-
ment is normally taken for granted, with researchers using
trainings and certifications for photographers17,18 or manu-
ally “cleaning” the datasets;19 some authors have even
used quality filters on algorithms before training the
algorithms.20
Optretina is a telemedicine platform which performs
general screening for retinal diseases using nonmydriatic
cameras and human evaluation by a retinal specialist
ophthalmologist.21 Our research in artificial intelligence
deals with both data acquisition and the diagnostic steps
of our telemedicine platform, in a near future we expect AI
could assist our specialists in achieving levels of consis-
tency and accuracy beyond unassisted human abilities.
This study aims to evaluate the capacity of AI methods
for solving several tasks related to our CADx pipeline. We
automatically discard inputs that are not derived from
color fundus photography (CFP); next we filter out images
that do not pass our quality threshold; we then differentiate
the right eye from the left eye; and finally, we proceed to
the diagnosis, using the remaining images and our algo-
rithms for AMD and suspected glaucoma.
Methods
Datasets
Optretina has been carrying out a telemedicine screening
program since 2013 in optical centers and since 2017 in
workplace offices and private companies. This study is
based on the tagged dataset from Optretina, composed of
306,302 retinal images. Labelled with diagnosis, laterality
and quality. Ophthalmologists—all of whom are retinal
specialists—have evaluated all of these images. The data-
set is real-life (Not from clinical trials) and anonymized,
composed of approximately 80% cases of normal retinas
and 20% abnormal ones. Images are acquired using NMC
(color fundus and red free) and optical coherence tomo-
graphy (OCT). The dataset includes images from different
types and brands of cameras. Figure 1 shows the distribu-
tion of the different cameras used, by percentage. The
dataset includes color fundus photography (CFP), macu-
lar OCT’s, retinal nerve fiber layer OCT (RNFL), and
other added non-medical images trying to fool the AI
(such as round objects like pizzas or photos of the full
moon). Of the 306,302 images, over 250,000 correspond
to CFP. In 2017, Optretina published the results of three
years of screenings,17 detailing the percentages of dis-
eases found.
Classification of image type (CFP, OCT, others) and
eye of evaluation (right or left) was performed by one
ophthalmologist. Labeling for quality assessment, pre-
sence of AMD, or glaucomatous optic neuropathy (GON)
was performed by two independent retinal specialists,
a third ophthalmologist assessed cases where there was
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no agreement, in order to establish at least two consistent
gradings. Since Optretina performs screenings and patients
in whom pathology is detected are subsequently referred to
an ophthalmologist, repetition of images of the same
patient are very rare. It is estimated that 0.5% of the
dataset images may be of patients already assessed in
previous years. The dataset was divided by patient in two
splits: training (80%) and testing (20%). 10% of the train-
ing split was used for validation purposes during the
training process of the models. Table 1 displays the
number of images used for each deep learning model, the
number of classes per model, and the number of ophthal-
mologists who independently labeled the same dataset.
Convolutional Neuronal Networks (CNNs)
The first three CNN models (trained from scratch) were
used for different image classification tasks usually
applied in data-collection, data-selection, display, and
data classification. The first model is very useful for
cleaning unlabeled datasets, since it can separate the
Figure 1 Distribution of nonmydriatic cameras (NMCs) and optical coherence tomography (OCT) used for the dataset. Only central retinal images were included.
Table 1 Number of Images Used for Training the CNNs. Images Were Divided into Two Groups: One for Training the Model and
Another Naïve Group for Validating the Training Procedure. Color Fundus photography (CFP), Optical coherence tomography (OCT),
Retinal nerve fiber layer (RNFL), Right eye (OD), Left eye (OS), Age related macular degeneration (AMD), referable glaucomatous
optic neuropathy (GON).
Model Classification Task Images for
Training
Data Augmentation
from Keras
Number of
Classes
Number of Ophthalmologists for
Label the Images
1 Image type selection
CFP/OCT/RFNL/OTHER
56,396 Shear_range=0.2,
zoom_range=0.2
4 1
2 Data Collection Good
quality images
150,075 Shear_range=0.2,
zoom_range=0.2
2 3
3 Data Display
OD/OS
30,119 Shear_range=0.2,
zoom_range=0.2
2 1
4 AMD 8832 Zoom_range 0.1
rotation_range 10
horizontal_flip: True
2 3
5 GON 3776 Zoom_range 0.1
rotation_range 15
horizontal_flip: True
2 3
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CFP images from OCT or other type of images like red-
free image, autofluorescence, angiographic images or
other. The second model allows us to select only the
CFP with a minimum threshold of image quality. The
third model helps us to classify right-eye CFP versus
left-eye CFP, which we use in our platform to display the
best pair of retinas per patient. The fourth model classi-
fies the AMD CFP versus the normal CFP. Finally, the
fifth model allows for the classification of normal CFP
versus GON. Table 2 presents the three main CNN. We
have also published sample code for these architectures
on https://github.com/octavifs/optretina-cnns.
Model 1: Image Type Selection CFP/OCT/Other
Images
The CNN-1 performs a binary classification, separating CFP
from all other image types (OCT/RNFL/other images). The
training process was done from scratch, using RGB images
resized to 128x128 pixels with geometric data augmentation
over the training dataset. It should be noted that the CNN-1
has only three convolution layers, three max pooling layers,
and three dense layers; as a result, the CNN-1 has fewer
parameters than very deep models (such as Inception, VGG-
19, and RESNET50, among others). Its shallow architecture
makes it computationally inexpensive, which is beneficial
for increasing the processing throughput of our CADx pipe-
line. CNN-1, along with the rest of the models, have been
implemented using Keras,22 a software library that facilitates
the creation of neural networks with access to specialized
hardware resources, such as graphics processing units
(GPUs), in order to speed up the training and execution of
such algorithms.
Model 2: Good Quality Retinal Fundus Image
Classification
The second model also implements CNN-1 architec-
ture, but for a different task: to select good quality
CFP. The definition of “good quality” was defined by
considering the color retinal fundus image, centered on
macula with a correct focus; good visualization of the
parafoveal vessels; and if it was possible to visualize
over two disc diameters around the fovea, the optic
Table 2 CNN Architecture for Algorithms: 1. Color Fundus Photography (CFP) versus Macular Optical Coherence Tomography
(OCT), Retinal Nerve Fiber Layer in the OCT and Other images. 2. Good Quality Retinal Fundus image. 3. Right Eye versus Left Eye
(OD/OS). 4. AMD. 5. Glaucomatous Optic Neuropathy (GON) Classification. (Notations are Based on Keras22)
CNN-1 AMD-Net GON-Net
Input (128,128,3) Input (512,512,3) Input (224,224,3)
Conv_2D_1(ReLu,3,3,32) Conv_2D_1(ReLu,5,5,32) RESNET50
Max_Pooling_1(2,2) Max_Pooling_1(2,2) Flatten
Conv_2D_2(ReLu,3,3,32) Conv_2D_2(ReLu,3,3,32) Dropout_1(0.5)
Max_Pooling_2(2,2) Conv_2D_3(ReLu,3,3,32) Dense_1(ReLu,64)
Conv_2D_3(ReLu,3,3,64) Max_Pooling_2(2,2) Dropout_2(0.2)
Max_Pooling_3(2,2) Conv_2D_4(ReLu,3,3,32) Dense_2 (Softmax, 2)
Flatten Conv_2D_5(ReLu,3,3,32)
Dense_1 (ReLu,64) Max_Pooling_3(2,2)
Dropout_1 (0,5) Conv_2D_6(ReLu,3,3,32)
Dense_2 (Sigmoid, 5*/2) Conv_2D_7(ReLu,3,3,32)
Max_Pooling_4(2,2)
We trained only for 50 epochs, batch
size of 32 and learning rate of 0.001 for each model.
Conv_2D_8(ReLu,3,3,32)
Conv_2D_9(ReLu,3,3,32)
Max_Pooling_5(2,2)
Conv_2D_10(ReLu,3,3,64)
Conv_2D_11(ReLu,3,3,64)
Max_Pooling_6(2,2)
Flatten
Dense_1(ReLu64)
Dropout_1(0.5)
Dense_2(ReLu,64)
Dropout_2(0.2)
Dense_2 (Softmax, 2)
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disc (at least three-quarters), and the vascular arcades.
Figure 2 shows an example of good and bad quality
retinal fundus images. We also trained the same CNN-1
from scratch for a different objective with geometric
data augmentation.
Model 3: Right-Eye versus Left-Eye (OD/OS)
Classification
The third model is very useful for automatically displaying
both CFP images of the same patient in order for the
ophthalmologist to label the images. We trained the
model from scratch with data augmentation and using
CNN-1 architecture in order to classify the left eye versus
the right eye. It is important to note that the same simple
architecture was useful for classifying images in different
tasks. However, while the architecture is the same, each
training process teaches the model the features necessary
to learn a specific task.
Model 4: Age-Related Macular Degeneration (AMD)
AMD image classification poses special challenges due to
the fact that images are almost identical and only small
features determine their class.
AMD was classified according to the international
classification published in 2013:23
● Early AMD: the presence of medium drusen within
two disc diameters (DD) of the fovea.
● Intermediate AMD: the presence of large drusen or
medium drusen with pigmented abnormalities within
two DDs from the center.
● Advanced AMD: the presence of geographic atrophy
(> 125 microns) or signs of choroidal neovascular-
ization or fibrosis within two DDs from the fovea.
Although the images were classified into the three stages
of AMD for further investigations, this first algorithm was
binary, and detected AMD retinas (at any stage) from
normal ones.
We propose a novel architecture for AMD binary classi-
fication which will be referred to hereinafter as AMDNET.
The architecture of AMDNET allows us to extract small
details and features while also making predictions with
relatively few trainable parameters (around 241,000) in
comparison with other well-known architectures such as
RESNET5024 or InceptionV325 which have approximately
Figure 2 (A) Examples of good quality images. Retinal fundus images are centered on the macula with correct focus, good visualization of the parafoveal vessels and over
two disc diameters around the fovea, and correct observation of the optic disc (at least three-quarters) and the vascular arcades. (B) Examples of poor quality images.
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25 million trainable parameters. The AMDNET architecture
is presented in Table 2. We trained AMDNET from scratch
with the data specifications presented in Table 1.
Algorithm 5: Referable Glaucomatous Optic
Neuropathy (GON)
Referable glaucomatous optic neuropathy (GON) was
defined by a cup-to-disc ratio of 0.7 or more in the vertical
axis and/or other typical changes caused by glaucoma,
such as localized notches or RNFL defects. We modified
RESNET50 (23) and training from scratch in order to
make a binary GON image classification.
Study of Misclassifications
To study the possible cause of misclassification an experi-
enced retinal specialist and the Optretina medical director
(Miguel A. Zapata) reviewed all false positives and nega-
tives in the AMD and the GON algorithm.
Ethics and Data Protection
Given that requesting informed consent for the Optretina
evaluation is mandatory, patients are informed of the pros
and cons of screening, including the spectrum of diseases
that can and cannot be detected by a retinal fundus image.
As part of giving consent, patients also agreed to their
images being used anonymously for science and research
purposes. The dataset was completely anonymized. No
Optretina or BSC employee has access to patient data
except for the Optretina technical director (Didac Royo),
solely for emergency purposes. The keys for reversing the
anonymization are physically stored in a bank. The study
was approved by the ethics committee of the Hospital Vall
d’Hebron in Barcelona, the research followed the tenets of
the Declaration of Helsinki.
Statistical Analyses
A confusion matrix was created from the validation set in
all five CNNs. Images were divided based on the human
and algorithm classification. Receiver operating
characteristics (ROC) curves, area under the curve
(AUC), accuracy, and all other calculations were made
using SPSS 15. The number of images used for each
algorithm depended on the number of good images with
the disease in the Optretina database.
Results
Table 3 summarizes the outcomes from the different con-
volutional neuronal networks (CNNs) in the study. Table 4
reflects the confusion matrix in the validation sets, indicat-
ing positives and negatives, comparing human and artifi-
cial evaluation. ROC curves are seen in Figure 3.
The first CNN differentiating color fundus images from
other medical or non-medical images has an AUC of
0.979, with an accuracy of 96%. This algorithm has
a sensitivity over 97% and a specificity of 92%. Artificial
intelligence for determining if a retinal fundus image was
assessable or not had an accuracy of 92%, compared to
human determination and an AUC of 0.947. This CNN
also had high sensitivity (97%) and specificity (82%).
The algorithm for the right eye/left eye (OD/OS) had
an AUC of 0.989 with an accuracy of 97.4%. CNNs for
evaluating diseases had an AUC of 0.936 in the case of
age-related macular degeneration (AMD) with an accuracy
of 86.3%, and an AUC of 0.863 with an 80% accuracy in
the case of glaucomatous optic neuropathy. The algorithm
for detecting AMD had a sensitivity of 90.2% and
a specificity of 82.5%. In the case of glaucomatous optic
neuropathy (GON), sensitivity was 76.8% and specificity
was 83.8%.
The first cause of misclassification of images in the
AMD and the GON algorithm was the presence of border-
line cases. In the case of AMD, false negatives were early
AMD that was not seen by the CNN as disease; false
positives were cases of small drusen in the macular area
that were not tagged as AMD by the retinal specialist. False
negatives and positives in suspected glaucoma were border-
line cases with approximately 7/10 vertical excavation.
Table 3 Outcomes Calculated Using the Confusion Matrix in Different Algorithms
Model AUC Accuracy Sensitivity Specificity
Image type 0.979 (0.978 0.981) 0.960 (0.957 0.962) 0.977 (0.976 0.979) 0.924 (0.920 0.929)
Eye 0.989 (0.988 0.991) 0.974 (0.973 0.977) 0.983 (0.981 0.985) 0.966 (0.963 0.970)
Image quality 0.947 (0.945 0.948) 0.918 (0.916 0.919) 0.969 (0.968 0.970) 0.818 (0.814 0.821)
AMD classification 0.936 (0.922 0.946) 0.863 (0.845 0.877) 0.902 (0.880 0.916) 0.825 (0.799 0.849)
GON classification 0.863 (0.827 0.894) 0.803 (0.760 0.836) 0.768 (0.710 0.824) 0.838 (0.784 0.888)
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Discussion
For the last three years, artificial intelligence has been consid-
ered useful for detecting certain pathologies in retinal fundus
images. Studies show spectacular results for the detection of
diabetic retinopathy,14–17 macular degeneration,18,26 and cases
of suspected glaucoma.15,27,28
Optretina performs general screening for the main dis-
eases that affect the central retina. The screening is based
on retinal fundus images that use mainly table-top non-
mydriatic cameras (NMCs), although portable cameras
and optical coherence tomography (OCT) are also used.
The readings are conducted by specialist retina ophthal-
mologists who subsequently issue a report on the state of
the patient’s two central retinas. We think, in a near future
artificial intelligence could improve the times and quality
of reading, resulting in our readers having better outcomes
than human-only readings. In order for this to occur, we
must first guarantee the quality of the images. Since the
screening is based on retinal fundus images, we consider
the first three algorithms to be useful when the photogra-
pher (optometrist, general practitioner, or technician)
uploads the images on the telemedicine platform; in this
way, the system can detect that there is at least one retinal
fundus image for each eye and that the image is of a good
enough quality to be evaluated.
Unlike other publications that aim to replace the human
reading, we will like to explore future models based on the
idea that a hybrid reading—or the use of artificial intelli-
gence (AI) as a diagnostic aid tool can, at this time, be
a better solution for both guaranteeing the quality of the
readings and decreasing costs and time invested, while also
causing fewer ethical or legal problems. However, when
working with images from different types of cameras, and
even non-retinal fundus image images, studying the image
quality is even more important.
In the near future, screening for retinal diseases will
most probably be affected by the increasing ease with
which images will be able to be produced due to the
decreasing cost of NMCs and the use of smartphones and
portable digital devices. As other authors have described,
these procedures should be autonomous with little require-
ment for trained personnel.29 It has been well described that
the first step necessary for a screening algorithm is the
recognition and the exclusion of insufficient image
quality.29 This is what our first CNNs dealt with. In our
case, algorithms for identification and quality assurance
have levels of accuracy that are better than human-only.
Retinal landmarks have traditionally been used for recog-
nizing a retinal image and evaluating its quality,30,31 but we
used two CNNs without any intervention or segmentation,
thereby obtaining high levels of AUC for the algorithms.
To guarantee the quality of the images, some authors
perform a manual evaluation of their databases;16,29 while
this system is suitable for retrospective studies, using it in
prospective studies is not ideal. Other authors point out the
need for training and certifying photographers,19 which
certainly substantially improves the image quality. We
believe, however, that the use of quality algorithms may
be a more appropriate measure: it has a short feedback
circle, even during the image taking process, thus offering
a greater guarantee of quality and more cost-effectiveness.
Other authors have also used quality algorithms, as was
the case with Varadarajan et al,20 who had to exclude 12%
of the images of one of their datasets due to poor quality.
In the case of multiple acquisition devices and different
types of images—red free, color fundus photography
(CFP), autofluorescence, OCT, non-medical images—AI
could be used as a cascade of filters. First, we could
evaluate what kind of image we have, then the eye (in
Table 4 Validation ConfusionMatrix from the Five CNNs: 1. Color
Fundus Photography (CFP) versus Other Images. 2. Good Quality
Retinal Fundus Images. 3. Right Eye versus Left Eye (OD/OS). 4. Age
Related Macular Degeneration (AMD). 5. Glaucomatous Optic
Neuropathy (GON)
Filetype
Prediction False True
False 31% 2%
True 3% 64%
Laterality
Prediction False True
False 48% 1%
True 2% 49%
Quality assessment
Prediction False True
False 28% 2%
True 6% 64%
AMD
Prediction False True
False 42% 5%
True 9% 44%
GON
Prediction False True
False 42% 11%
True 8% 39%
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our model it is important to differentiated laterality, we
receive images from different cameras, automatically
upload in the platform, not all devices have differentiated
file from right or left eye) and if they are of sufficient
quality to be assessed; then we could apply CNNs for
different pathologies—in our case AMD and GON.
The use of AI could decrease the costs of screening
tools in the near future, allowing mass screening for retinal
disease in the general population and not just in known
diabetics. The incidence of AMD and glaucoma is currently
increasing around the world. These two diseases are
the second and third most frequent causes for visual impair-
ment in Europe,32 which is why we based our research on
them. Other publications on automated detection of refer-
able AMD with accuracies of 90% can be found in the
literature.18,26 With our CNNs, we have achieve 86% accu-
racy, because we have included all types of AMD, including
the early stages; at this point, one of the most important
reasons for misclassification is difficulty in differentiating
between early stages of AMD and normal retinas. We
believe that it is worthwhile for future research to study
the classification of AMD stages using AI in CFP, as other
authors demonstrate using OCT.33 For the purposes of our
current research, we prefer to identify any stage of AMD in
order to create future algorithms for classification. We
believe that although early AMD will not threaten visual
acuity in the short term, it should still be studied and
monitored by the ophthalmologist. In a recent review,
Schmidt-Erfurth et al indicate the limited role of CFP for
advanced stages of AMD compared to OCT screening,29
but for a general screening platform it may make sense to
start with color fundus photography due to cost considera-
tions. Also AI has detected patterns that are invisible to the
human eye in CFP such as gender, age, and smoking status.
Detection of advanced AMD in retinal fundus images
should therefore be studied.
Figure 3 Receiver operating characteristic (ROC) curves from the different CNNs. (A) Image type. (B) Quality assessment. (C) Laterality. (D) AMD. (E) GON.
Zapata et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Clinical Ophthalmology 2020:14426
   
                                 
Screening for glaucoma is much more complicated
than doing so for other ophthalmological diseases.
Authors have had the best outcomes with a combination
of the slit lamp, OCT retinal nerve fiber layer (RNFL), and
visual field tests, but this combination is not the modality
of choice when we want to consider devices that are low
cost, widely available, and easy to use.29 In the latter case,
we are limited to detecting suspected glaucoma by visua-
lizing only the optic disc, similar to Ting et al, who
obtained a 94% accuracy for possible glaucoma in
a dataset of 125,000 diabetic patients.15 In our case, with
only 4720 images in the suspected glaucoma algorithm,
we achieved levels of accuracy of over 80%. Further
research with a better-defined glaucoma database would
be desirable in order to reach the maximum potential for
AI in screening for this disease.
We believe the kind of technology discussed in this
paper could be used not only for prospective purposes, but
also in retrospective studies, for classification in non-tagged
big datasets such as hospitals or ophthalmological clinics.
We use AI for classification, but one of the most exciting
types of future implementation of CNNs could be the pre-
diction of disease progression or clinical data.29 In the near
future, application of big data will require a well-tagged
database, and AI could be very helpful in this arena—for
massive retrospective classifications of image datasets
The accuracy of CNNs appears to be related primarily
to two factors. The first factor is the similarity of classes,
and the second is the number of well-classified images.
Regarding the first factor, it is necessary to explore the use
of deep learning for fine-grained image classification tech-
niques, given that it is easy for CNNs to differentiate
a horse from a car but the complexity increases when
considering the classification of similar images.
Concerning the second factor, it is easier to obtain high
levels of accuracy if we have large and well-classified
datasets. Although we used data augmentation techniques
in order to improve validation accuracy, having a large
dataset could be very important for obtaining a robust and
more general prediction model. We believe false positives
could be avoided with larger and better-tagged datasets. In
our case, the main cause of false positives and negatives
were borderline cases—images with which even retinal
specialists have low interobserver agreement.
From an engineering point of view, we have shown that
it is possible to propose an effective CNN architecture
with high validation accuracy and fewer trainable para-
meters. We would like to explore the combination of
different types of architecture in a future study in order
to try to predict other retinopathies.
One of the limitations of this study is the inclusion of
multiples images, from multiple devices and photogra-
phers, some of which only include 40°, 45°, and 50º of
the central retina. However, this same limitation could also
be a strength for the resulting algorithms, which could be
more reliable for use in the real world without having to
worry about camera brands or types. The only significant
barrier would be the assessable AI filter.
From an ethical and legal point of view, AI is far from
being reliable for general screening for retinal diseases. AI
can detect DR, AMD, or suspected glaucoma perfectly, but
we have to see what would happen— and who is respon-
sible in the event the algorithm fails—when the system
evaluates an image with uncommon findings, such as
dystrophies, tumors, or minor infections. In our opinion,
this problem could be solved with bigger datasets that
include rare diseases. In the end, the more we teach the
AI system, the more it learns. Meanwhile, AI could be
used to ameliorate the cost-effectiveness of using hybrid
systems supervised by a medical expert, raising doctor’s
performance beyond unaided human-only abilities, also
would be desirable for furthers investigations evaluate AI-
assisted interpretation in other non-retinal specialist per-
sonnel such as general ophthalmologists or primary care
physicians.
Deep learning opens an exciting chapter for the future.
AI algorithms seem to be reliable for determining whether
or not an image is CFP. Those algorithms are useful for
evaluating the quality of the retinal fundus image and also
for determining DR, AMD, and suspected glaucoma. As
discussed earlier, the next steps will be to continue “feed-
ing the beast,” providing more and more classified images
to improve accuracy and creating new CNNs for other
diseases. One of the most exciting challenges ahead is
designing new networks for making the normal/abnormal
algorithm over 90% of accuracy. Apart from technical and
ethical limitations, medical doctors must also establish
how to incorporate the algorithm properly into our clinics
and offices in order to control it and ensure a good use of
AI technology in medicine.
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